A newly released COVID-19 Vaccine Packaging and Delivery Devices Market analysis report by Future Market Insights reveals that global sales of the Covid-19 Vaccine Packaging and Delivery Devices in 2022 were held at US$ 1.1 billion. With a CAGR of 7.1% from 2023 to 2033, the market is projected to reach a valuation of US$ 2.2 billion by 2033. Syringes is expected to be the highest revenue-generating segment, projected to grow at a CAGR of over 6.8% from 2023 to 2033.
| Attribute | Details |
|---|---|
| Global Covid-19 Vaccine Packaging and Delivery Devices Market (2023) | US$ 1.1 billion |
| Global Covid-19 Vaccine Packaging and Delivery Devices Market (2033) | US$ 2.2 billion |
| Global Covid-19 Vaccine Packaging and Delivery Devices Market CAGR (2023 to 2033) | 7.1% |
| The USA Covid-19 Vaccine Packaging and Delivery Devices Market CAGR (2023 to 2033) | 7.5% |
| Key Companies Profiled |
|
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
As per the COVID-19 Vaccine Packaging and Delivery Devices Market research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2018 to 2022, the market value of the COVID-19 Vaccine Packaging and Delivery Devices Market increased at around 5.9% CAGR.
COVID-19 Vaccine Packaging and Delivery systems demand escalated due to the high death rate from COVID-19 infection in comparison to other viral infections such as influenza. Thus, the global demand for COVID-19 vaccination presented a significant chance for growth in the market. The need to package and transportation of the vaccines in time considering their sterilized state has created opportunities for the global COVID-19 Vaccine Packaging and Delivery Devices Market.
Many pharmaceutical companies are engaged in research and development and are likely to fabricate new serums in the market when new strains emerge. As packaging and delivery are an important part of each product's manufacturing, the market has significant growth opportunities during the forecasted period.
The COVID-19 Vaccine Packaging and Delivery Devices Market is also likely to boost throughout the forecasted period owing to an increase in the demand for needle-free products to reduce pain and injuries associated with vaccination along with increased attempts to develop vaccine delivery systems.
The market is being largely driven by expanding immunization programs, expanding vaccination efforts and campaigns, and rising Covid occurrences globally. The increasing financial assistance from the government and non-governmental organizations has resulted in numerous innovations in the area, consequently increasing market size.
Additionally, with the increasing financing and efforts towards research and development, the market will further witness an upside move. These efforts are aimed at developing a new vaccine and developing packaging material and delivery devices.
The demand for COVID-19 Vaccine Packaging and Delivery Devices is huge, especially in countries like India and China, which have almost one-third of the world population. In addition, since these countries have been most active in the manufacturing of Covid-19 vaccines, there exist significant growth prospects for the market in these countries.
The huge spike in the number of people affected by the Covid-19 virus created a huge demand for vaccines worldwide. The huge demand led to an increase in the manufacturing of these vaccines in order to curb its menace. The rising prevalence of communicable diseases and strong support from the government for vaccine manufacturing are key factors that lead to the demand for Vaccine packing and delivery. With the increased investment in the research and development of various new vaccines, the demand for the market will continue a forward path.
However, there are factors that hinder the market growth with the research and development focused towards needle-free distribution, which stymies the market growth as the demand for Vials, and syringes would reduce, which are the key revenue components for the Covid-19 Vaccine packaging and delivery market.
Principal Consultant
In 2022, North America held the largest share of the global COVID-19 Vaccine Packaging and Delivery Devices market. The regional market is expected to be driven by fast expansion in the healthcare sector and increased awareness of the advantages of vaccination.
Rising confidence of the public in the authorized vaccines and because of public willingness to be vaccinated, the market in the Asia Pacific is expected to grow at a rapid pace during the forecast period. Moreover, the increasing patient pool along with unmet vaccine demand in untapped regions further adds to the expansion of the market. Also, the presence of developing nations like India and China is expected to further boost the market.
The United States is expected to have the highest market share of US$ 776 million by the end of 2033. The growth of the Covid-19 Vaccine Packaging and Delivery Devices market in the United States can be attributed to increased Research and Development (R&D) spending to bring advances in vaccination devices. Furthermore, the existence of strong players like Johnson & Johnson, Pfizer, and Moderna will drive the market in the country.
The market in the United Kingdom is expected to reach a valuation of US$ 94 million by 2033, growing at a CAGR of 7.3% from 2023 to 2033. The market is projected to gross an absolute dollar opportunity of US$ 48 million during the forecast period.
In Japan, the market is expected to reach a valuation of US$ 115 million by 2033. During the forecast period, the market in the country is expected to garner an absolute dollar opportunity of US$ 66 million, growing at a CAGR of 8.9%.
The market in South Korea is projected to grow at a CAGR of 8.4% from 2023 to 2033. During this period, the market is projected to witness an absolute dollar opportunity of US$ 27 million and reach US$ 49 million by 2033.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Syringes commanded the largest revenue in the market, grew at a CAGR of nearly 5.4% from 2018 to 22, and are now forecasted to grow at a CAGR of 6.8% throughout the forecasted period. This is due to the advantages of using syringes over other alternatives. These are easy to use and distribute and at the same time are available at low cost. With the increased focus on research and technological advancements in syringes will significantly propel the market growth.
Collaboration, partnership, and acquisitions are common methods used by leading players in the worldwide vaccine delivery devices market.
Some of the key players in the Covid-19 Vaccine Packaging and Delivery Devices Market include Stevanto Group, Schott AG, Gerresheimer AG, West Pharmaceutical Services Inc., Becton Dickinson and Company, SGD Pharma, Catalent Inc., B. Braun Melsungen AG, AptarGroup Inc., Cardinal Health Inc., Sealed Air Corporation, Hindustan Syringes & Medical Devices Ltd., NIPRO Corporation, PGP Glass Private Limited, Zhejiang Kangkang Medical-Devices Co Ltd, Anhui JN Medical Device Co. Ltd., and Zhejiang Jinghuan Medical Apparatus Co. Ltd.
Some of the recent developments of key COVID-19 Vaccine Packaging and Delivery Devices providers are as follows:
Stevanto Group, Schott AG, and Gerresheimer AG are key players.
The market is forecasted to register a CAGR of 7.1% through 2033.
In 2022, North America held an exponential share of the global COVID-19 Vaccine Packaging and Delivery Devices market.
During 2018 to 2022, the market grew at a CAGR of 5.9%.
The United States, Japan, and China dominate the global market.
1. Executive Summary | COVID-19 Vaccine Packaging and Delivery Devices Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Investment Feasibility Matrix
3.6. PESTLE and Porter’s Analysis
3.7. Regulatory Landscape
3.7.1. By Key Regions
3.7.2. By Key Countries
3.8. Regional Parent Market Outlook
4. Global Covid-19 Vaccine Packaging and Delivery Devices Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Covid-19 Vaccine Packaging and Delivery Devices Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ million) Analysis By Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Type, 2023 to 2033
5.3.1. Vials
5.3.1.1. Glass
5.3.1.2. Plastic
5.3.2. Syringes
5.3.2.1. Empty
5.3.2.2. Prefilled
5.4. Y-o-Y Growth Trend Analysis By Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Type, 2023 to 2033
6. Global Covid-19 Vaccine Packaging and Delivery Devices Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
6.1. Introduction
6.2. Historical Market Size Value (US$ million) Analysis By Region, 2018 to 2022
6.3. Current Market Size Value (US$ million) Analysis and Forecast By Region, 2023 to 2033
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa
6.4. Market Attractiveness Analysis By Region
7. North America Covid-19 Vaccine Packaging and Delivery Devices Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
7.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2018 to 2022
7.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033
7.2.1. By Country
7.2.1.1. The USA
7.2.1.2. Canada
7.2.2. By Type
7.3. Market Attractiveness Analysis
7.3.1. By Country
7.3.2. By Type
7.4. Key Takeaways
8. Latin America Covid-19 Vaccine Packaging and Delivery Devices Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
8.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2018 to 2022
8.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033
8.2.1. By Country
8.2.1.1. Brazil
8.2.1.2. Mexico
8.2.1.3. Rest of Latin America
8.2.2. By Type
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Type
8.4. Key Takeaways
9. Europe Covid-19 Vaccine Packaging and Delivery Devices Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. Germany
9.2.1.2. The United Kingdom
9.2.1.3. France
9.2.1.4. Spain
9.2.1.5. Italy
9.2.1.6. Russia
9.2.1.7. Rest of Europe
9.2.2. By Type
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Type
9.4. Key Takeaways
10. Asia Pacific Covid-19 Vaccine Packaging and Delivery Devices Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. China
10.2.1.2. Japan
10.2.1.3. India
10.2.1.4. South Korea
10.2.1.5. Australia
10.2.1.6. Rest of APAC
10.2.2. By Type
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Type
10.4. Key Takeaways
11. Middle East and Africa Covid-19 Vaccine Packaging and Delivery Devices Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. South Africa
11.2.1.2. Saudi Arabia
11.2.1.3. UAE
11.2.1.4. Israel
11.2.1.5. Rest of Middle East and Africa (MEA)
11.2.2. By Type
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Type
11.4. Key Takeaways
12. Key Countries Covid-19 Vaccine Packaging and Delivery Devices Market Analysis
12.1. The USA
12.1.1. Pricing Analysis
12.1.2. Market Share Analysis, 2022
12.1.2.1. By Type
12.2. Canada
12.2.1. Pricing Analysis
12.2.2. Market Share Analysis, 2022
12.2.2.1. By Type
12.3. Brazil
12.3.1. Pricing Analysis
12.3.2. Market Share Analysis, 2022
12.3.2.1. By Type
12.4. Mexico
12.4.1. Pricing Analysis
12.4.2. Market Share Analysis, 2022
12.4.2.1. By Type
12.5. Germany
12.5.1. Pricing Analysis
12.5.2. Market Share Analysis, 2022
12.5.2.1. By Type
12.6. The United Kingdom
12.6.1. Pricing Analysis
12.6.2. Market Share Analysis, 2022
12.6.2.1. By Type
12.7. France
12.7.1. Pricing Analysis
12.7.2. Market Share Analysis, 2022
12.7.2.1. By Type
12.8. Spain
12.8.1. Pricing Analysis
12.8.2. Market Share Analysis, 2022
12.8.2.1. By Type
12.9. Italy
12.9.1. Pricing Analysis
12.9.2. Market Share Analysis, 2022
12.9.2.1. By Type
12.10. Russia
12.10.1. Pricing Analysis
12.10.2. Market Share Analysis, 2022
12.10.2.1. By Type
12.11. China
12.11.1. Pricing Analysis
12.11.2. Market Share Analysis, 2022
12.11.2.1. By Type
12.12. Japan
12.12.1. Pricing Analysis
12.12.2. Market Share Analysis, 2022
12.12.2.1. By Type
12.13. India
12.13.1. Pricing Analysis
12.13.2. Market Share Analysis, 2022
12.13.2.1. By Type
12.14. South Korea
12.14.1. Pricing Analysis
12.14.2. Market Share Analysis, 2022
12.14.2.1. By Type
12.15. Australia
12.15.1. Pricing Analysis
12.15.2. Market Share Analysis, 2022
12.15.2.1. By Type
12.16. South Africa
12.16.1. Pricing Analysis
12.16.2. Market Share Analysis, 2022
12.16.2.1. By Type
12.17. Saudi Arabia
12.17.1. Pricing Analysis
12.17.2. Market Share Analysis, 2022
12.17.2.1. By Type
12.18. UAE
12.18.1. Pricing Analysis
12.18.2. Market Share Analysis, 2022
12.18.2.1. By Type
12.19. Israel
12.19.1. Pricing Analysis
12.19.2. Market Share Analysis, 2022
12.19.2.1. By Type
13. Market Structure Analysis
13.1. Competition Dashboard
13.2. Competition Benchmarking
13.3. Market Share Analysis of Top Players
13.3.1. By Regional
13.3.2. By Type
14. Competition Analysis
14.1. Competition Deep Dive
14.1.1. Stevanto Group
14.1.1.1. Overview
14.1.1.2. Product Portfolio
14.1.1.3. Profitability by Market Segments
14.1.1.4. Sales Footprint
14.1.1.5. Strategy Overview
14.1.1.5.1. Marketing Strategy
14.1.2. Gerresheimer AG
14.1.2.1. Overview
14.1.2.2. Product Portfolio
14.1.2.3. Profitability by Market Segments
14.1.2.4. Sales Footprint
14.1.2.5. Strategy Overview
14.1.2.5.1. Marketing Strategy
14.1.3. West Pharmaceutical Services Inc.
14.1.3.1. Overview
14.1.3.2. Product Portfolio
14.1.3.3. Profitability by Market Segments
14.1.3.4. Sales Footprint
14.1.3.5. Strategy Overview
14.1.3.5.1. Marketing Strategy
14.1.4. Becton Dickinson and Company
14.1.4.1. Overview
14.1.4.2. Product Portfolio
14.1.4.3. Profitability by Market Segments
14.1.4.4. Sales Footprint
14.1.4.5. Strategy Overview
14.1.4.5.1. Marketing Strategy
14.1.5. SGD Pharma
14.1.5.1. Overview
14.1.5.2. Product Portfolio
14.1.5.3. Profitability by Market Segments
14.1.5.4. Sales Footprint
14.1.5.5. Strategy Overview
14.1.5.5.1. Marketing Strategy
14.1.6. Catalent Inc.
14.1.6.1. Overview
14.1.6.2. Product Portfolio
14.1.6.3. Profitability by Market Segments
14.1.6.4. Sales Footprint
14.1.6.5. Strategy Overview
14.1.6.5.1. Marketing Strategy
14.1.7. B. Braun Melsungen AG
14.1.7.1. Overview
14.1.7.2. Product Portfolio
14.1.7.3. Profitability by Market Segments
14.1.7.4. Sales Footprint
14.1.7.5. Strategy Overview
14.1.7.5.1. Marketing Strategy
14.1.8. AptarGroup Inc.
14.1.8.1. Overview
14.1.8.2. Product Portfolio
14.1.8.3. Profitability by Market Segments
14.1.8.4. Sales Footprint
14.1.8.5. Strategy Overview
14.1.8.5.1. Marketing Strategy
14.1.9. Cardinal Health Inc.
14.1.9.1. Overview
14.1.9.2. Product Portfolio
14.1.9.3. Profitability by Market Segments
14.1.9.4. Sales Footprint
14.1.9.5. Strategy Overview
14.1.9.5.1. Marketing Strategy
14.1.10. Sealed Air Corporation
14.1.10.1. Overview
14.1.10.2. Product Portfolio
14.1.10.3. Profitability by Market Segments
14.1.10.4. Sales Footprint
14.1.10.5. Strategy Overview
14.1.10.5.1. Marketing Strategy
14.1.11. Hindustan Syringes & Medical Devices Ltd.
14.1.11.1. Overview
14.1.11.2. Product Portfolio
14.1.11.3. Profitability by Market Segments
14.1.11.4. Sales Footprint
14.1.11.5. Strategy Overview
14.1.11.5.1. Marketing Strategy
14.1.12. NIPRO Corporation
14.1.12.1. Overview
14.1.12.2. Product Portfolio
14.1.12.3. Profitability by Market Segments
14.1.12.4. Sales Footprint
14.1.12.5. Strategy Overview
14.1.12.5.1. Marketing Strategy
14.1.13. PGP Glass Private Limited
14.1.13.1. Overview
14.1.13.2. Product Portfolio
14.1.13.3. Profitability by Market Segments
14.1.13.4. Sales Footprint
14.1.13.5. Strategy Overview
14.1.13.5.1. Marketing Strategy
14.1.14. Zhejiang Kangkang Medical-Devices Co Ltd
14.1.14.1. Overview
14.1.14.2. Product Portfolio
14.1.14.3. Profitability by Market Segments
14.1.14.4. Sales Footprint
14.1.14.5. Strategy Overview
14.1.14.5.1. Marketing Strategy
14.1.15. Anhui JN Medical Device Co. Ltd.
14.1.15.1. Overview
14.1.15.2. Product Portfolio
14.1.15.3. Profitability by Market Segments
14.1.15.4. Sales Footprint
14.1.15.5. Strategy Overview
14.1.15.5.1. Marketing Strategy
14.1.16. Zhejiang Jinghuan Medical Apparatus Co. Ltd.
14.1.16.1. Overview
14.1.16.2. Product Portfolio
14.1.16.3. Profitability by Market Segments
14.1.16.4. Sales Footprint
14.1.16.5. Strategy Overview
14.1.16.5.1. Marketing Strategy
14.1.17. Schott AG
14.1.17.1. Overview
14.1.17.2. Product Portfolio
14.1.17.3. Profitability by Market Segments
14.1.17.4. Sales Footprint
14.1.17.5. Strategy Overview
14.1.17.5.1. Marketing Strategy
15. Assumptions & Acronyms Used
16. Research Methodology
Explore Healthcare Insights
View Reports
COVID-19 Vaccine Packaging and Delivery Devices Market
